Share. Connect. Create. Grow. · Socialiya
Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients

A pancreatic cancer vaccine called mKRAS-VAX triggered a KRAS mutation-targeted immune response in 9...

HEALTH NEWS July 22, 2026

Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients

A pancreatic cancer vaccine called mKRAS-VAX triggered a KRAS mutation-targeted immune response in 90% of participants in a Johns Hopkins phase 1 trial.

10 views 0 likes 0 comments
Share:
A pancreatic cancer vaccine called mKRAS-VAX triggered a KRAS mutation-targeted immune response in 90% of participants in a Johns Hopkins phase 1 trial.

Author: Fox News

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya